Marlène Perrin-Niquet

机构：Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon · ORCID：0009-0006-1496-4590

发表论文 12 篇 · 总被引 34 次 · h-index 3

代表论文

• NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer (2024 · The Journal of Experimental Medicine · 被引 17)
• Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial (2024 · Clinical Cancer Research · 被引 9)
• A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis (2021 · Scientific Reports · 被引 8)
• Data from Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial (2024)
• Supplementary Figure 1-3 from Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial (2024)
• Supplementary Tables 1-4 from Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial (2024)